Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Quinoline-derivative coordination compounds as potential applications to antibacterial and antineoplasic drugs

Full text
Author(s):
Chagas, Camila dos Santos [1] ; Fonseca, Fernando L. A. [1, 2] ; Bagatin, Izilda A. [1]
Total Authors: 3
Affiliation:
[1] Univ Fed Sao Paulo, Lab Quim Calixarenos Espectroscopia Mol & Catalis, Inst Ciencias Ambientais Quim & Farmaceut, Rua Prof Arthur Riedel 275, BR-09972270 Diadema, SP - Brazil
[2] Fac Med ABC, Lab Anal Clin, Av Principe Gales 821, BR-09060650 Santo Andre, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Materials Science & Engineering C-Materials for Biological Applications; v. 98, p. 1043-1052, MAY 2019.
Web of Science Citations: 0
Abstract

Quinoline-derivative coordination compounds were synthesized with Zn(II), Al(III), Cu(II), Ru(II) producing 1-4 compounds using 5-nitro-8-hydroxyquinoline and 5-8 compounds using 5-chloro-8-hydroxyquinoline. These coordination compounds were characterized by elemental analysis and H-1 NMR, IR, UV-Vis and fluorescence spectroscopies, representing the coherent data matched all compounds. Myelotoxicity data, as well as the biochemical data, depicted the compounds have low cytotoxicity towards the blood cells. All coordination compounds displayed slight antimicrobial activity against E. coil, S. aureus, P. aeruginosa and E. faecalis; {[}RuCl(NO) (5-chloro-8-oxyquinoline)(2)] compound (8) represent the best result to inhibitions of Gram-positive and Gramnegative bacteria. Antineoplasic action depicted the {[}Ru(NO)(5-nitro-8-oxyquinoline)(2)Cl] compound (4) as a potential chemotherapeutic agent against MCF-7 (a breast cancer cell line), compared to cisplatin (Platistine (R) CS) and cyclophosphamide (Genuxal (R)) drugs. (AU)

FAPESP's process: 15/20485-4 - Calixarenes and iminic ligands developed for sensors, luminescent and bioinorganic compounds
Grantee:Izilda Aparecida Bagatin
Support Opportunities: Regular Research Grants